Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27

被引：0

作者：

Gregucci, Fabiana ^{[1
]}

Carbonara, Roberta ^{[1
]}

Fiorentino, Alba ^{[1
]}

机构：

[1] F Miulli Gen Reg Hosp, Dept Radiat Oncol, Str Prov 127 Acquaviva Santeramo Km 4,100, I-70021 Bari, Italy

来源：

EUROPEAN UROLOGY | 2020年 / 78卷 / 03期

关键词：

RADIATION; THERAPY;

D O I：

10.1016/j.eururo.2020.05.034

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E114 / E115

页数：2

共 9 条

[1] Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27
Montorsi, Francesco
Salonia, Andrea
Briganti, Alberto
EUROPEAN UROLOGY, 2020, 78 (05) : E192 - E192
[2] Reply to Francesco Montorsi, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27
Moris, Lisa
Mottet, Nicolas
Wiegel, Thomas
EUROPEAN UROLOGY, 2020, 78 (05) : E193 - E194
[3] Reply to Fabiana Gregucci, Roberta Carbonara, and Alba Fiorentino's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27
Moris, Lisa
Mottet, Nicolas
Wiegel, Thomas
EUROPEAN UROLOGY, 2020, 78 (03) : E116 - E117
[4] Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27
Moris, Lisa
Van den Broeck, Thomas
Wiegel, Thomas
EUROPEAN UROLOGY, 2020, 78 (03) : E120 - E121
[5] Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
Chin, Joseph L.
Bauman, Glenn S.
EUROPEAN UROLOGY, 2020, 78 (05) : 765 - 766
[6] Benefits and Risks of Primary Treatments for High -risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
Moris, Lisa
Cumberbatch, Marcus G.
Van den Broeck, Thomas
Gandaglia, Giorgio
Fossati, Nicola
Kelly, Brian
Pal, Raj
Briers, Erik
Cornford, Philip
De Santis, Maria
Fanti, Stefano
Gillessen, Silke
Grummet, Jeremy P.
Henry, Ann M.
Lam, Thomas B. L.
Lardas, Michael
Liew, Matthew
Mason, Malcolm D.
Omar, Muhammad Imran
Rouviere, Olivier
Schoots, Ivo G.
Tilki, Derya
van den Bergh, Roderick C. N.
van Der Kwast, Theodorus H.
van Der Poel, Henk G.
Willemse, Peter-Paul M.
Yuan, Cathy Y.
Konety, Badrinath
Dorff, Tanya
Jain, Suneil
Mottet, Nicolas
Wiegel, Thomas
EUROPEAN UROLOGY, 2020, 77 (05) : 614 - 627
[7] Re: Thomas Van den Broeck, Roderick CN van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87
Zhou, Xueliang
Han, Xinwei
EUROPEAN UROLOGY, 2019, 76 (01) : E15 - E15
[8] Reply to Xueliang Zhou and Xinwei Han's Letter to the Editor re: Thomas Van den Broeck, Roderick CN van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87
van den Broeck, Thomas
Mottet, Nicolas
Lam, Thomas
EUROPEAN UROLOGY, 2019, 76 (01) : E16 - E16
[9] Re: Nicola Fossati, Peter-Paul M. Willemse, Thomas Van den Broeck, et al. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol 2017; 72:84-109 Lymphadenectomy and Radical Prostatectomy: Science or Pseudoscience?
Clarke, Noel W.
EUROPEAN UROLOGY, 2018, 73 (03) : E75 - E76

← 1 →